United States Pharmaceuticals

Viatris Inc (VTRS)

Track

Track

Viatris Inc. experienced recent insider trading activity characterized by divestments. Officer Paul Campbell executed planned sales totaling approximately 1.6 million dollars over the last quarter. These transactions occurred following a positive earnings report, while the stock price maintains a strong position near its fifty-two-week high, reflecting a 6.7 percent gain over ninety days.
Ticker: VTRS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Viatris Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Campbell Paul See Remarks Officer
Transaction date
Planned sale
Price
172.53
Quantity 84,922 -17.3%
Value US$2,851,349
2.9
Paul Campbell Officer Officer
Transaction date
Proposed sale
Price
423.05
Quantity 18,531
Value US$607,162
2.9
Campbell Paul See Remarks Officer
Transaction date
Sale
Price
227.69
Quantity 49,078 -14.7%
Value US$139,225
2.9
Paul Campbell Officer Officer
Transaction date
Proposed sale
Price
13.28
Quantity 21,350
Value US$283,508
3.0
SIMMONS DAVID S Non-Executive Director
Transaction date
Purchase
Price
10.43
Quantity 213 +22.0%
Value US$2,221
Le Goff Corinne Chief Commercial Officer Officer
Transaction date
Planned sale
Price
10.25
Quantity 7,032 -16.6%
Value US$72,045
Le Goff Corinne Officer Officer
Transaction date
Proposed sale
Price
10.25
Quantity 7,032
Value US$72,045
3.0
SIMMONS DAVID S Non-Executive Director
Transaction date
Purchase
Price
10.42
Quantity 286 +41.8%
Value US$2,981
4.1
Smith Scott Andrew Chief Executive Officer Executive Director
Transaction date
Purchase
Price
9.99
Quantity 22,000 +7.5%
Value US$219,740
4.1
Smith Scott Andrew Chief Executive Officer Executive Director
Transaction date
Purchase
Price
8.94
Quantity 60,000 +25.8%
Value US$536,262
2.9
Campbell Paul Officer Officer
Transaction date
Proposed sale
Price
12.88
Quantity 26,925
Value US$346,686
2.9
Campbell Paul See Remarks Officer
Transaction date
Sale
Price
12.88
Quantity 26,925 -17.5%
Value US$346,686
1.9
Malik Rajiv Non-Executive Director
Transaction date
Sale
Price
11.66
Quantity 139,681 -21.6%
Value US$1,628,164
1.9
Malik Rajiv Non-Executive Director
Transaction date
Sale
Price
11.71
Quantity 60,319 -100.0%
Value US$706,553
1.9
Malik Rajiv Non-Executive Director
Transaction date
Sale
Price
12.00
Quantity 50,000 -45.3%
Value US$600,000
1.9
Malik Rajiv Non-Executive Director
Transaction date
Sale
Price
11.90
Quantity 50,000 -31.2%
Value US$595,075
1.9
Malik Rajiv Non-Executive Director
Transaction date
Sale
Price
11.75
Quantity 100,000 -38.4%
Value US$1,175,100
1.9
Malik Rajiv Non-Executive Director
Transaction date
Sale
Price
11.73
Quantity 100,000 -27.8%
Value US$1,172,630
1.9
Malik Rajiv Non-Executive Director
Transaction date
Sale
Price
11.75
Quantity 100,000 -21.7%
Value US$1,175,260
1.9
Malik Rajiv Director Non-Executive Director
Transaction date
Proposed sale
Price
11.80
Quantity 600,000
Value US$7,080,000
1.9
Malik Rajiv Non-Executive Director
Transaction date
Sale
Price
10.18
Quantity 264,300 -29.0%
Value US$2,690,283
1.9
Malik Rajiv Non-Executive Director
Transaction date
Sale
Price
10.52
Quantity 85,660 -8.6%
Value US$900,741
1.9
Malik Rajiv Affiliate
Transaction date
Proposed sale
Price
10.44
Quantity 350,000
Value US$3,654,000
0.9
Roman Brian Officer Officer
Transaction date
Proposed sale
Price
10.38
Quantity 89,419
Value US$928,427
0.9
Roman Brian Chief Legal Officer Officer
Transaction date
Sale
Price
10.38
Quantity 89,419 -56.9%
Value US$928,429
2.9
Mauro Anthony See Remarks Officer
Transaction date
Sale
Price
12.09
Quantity 250,000 -50.7%
Value US$3,023,700
2.9
Mauro Anthony Officer Officer
Transaction date
Proposed sale
Price
12.30
Quantity 250,000
Value US$3,075,000
2.9
Campbell Paul Officer Officer
Transaction date
Proposed sale
Price
12.33
Quantity 24,353
Value US$300,272
Lyons Dillon JoEllen Director Non-Executive Director
Transaction date
Proposed sale
Price
12.36
Quantity 20,000
Value US$247,200
2.9
Campbell Paul See Remarks Officer
Transaction date
Sale
Price
12.33
Quantity 24,353 -13.7%
Value US$300,272
Lyons Dillon JoEllen Non-Executive Director
Transaction date
Planned sale
Price
12.36
Quantity 20,000 -25.4%
Value US$247,200
3.0
Ni Xiangyang (Sean) President, Greater China Officer
Transaction date
Sale
Price
12.36
Quantity 3,777 -4.0%
Value US$46,677
3.0
Ni Xiangyang (Sean) President, Greater China Officer
Transaction date
Sale
Price
12.54
Quantity 17,755 -15.8%
Value US$222,637
3.0
Ni Xiangyang (Sean) Officer Officer
Transaction date
Proposed sale
Price
12.54
Quantity 22,000
Value US$275,880
Cuneo Andrew Officer Officer
Transaction date
Proposed sale
Price
13.50
Quantity 4,000
Value US$54,000
Cuneo Andrew See Remarks Officer
Transaction date
Planned sale
Price
13.50
Quantity 4,000 -10.3%
Value US$54,000
Cuneo Andrew See Remarks Officer
Transaction date
Planned sale
Price
12.50
Quantity 4,000 -9.3%
Value US$50,000
Cuneo Andrew Officer Officer
Transaction date
Proposed sale
Price
12.50
Quantity 4,000
Value US$50,000
Cuneo Andrew See Remarks Officer
Transaction date
Planned sale
Price
11.50
Quantity 4,000 -8.5%
Value US$46,000
Cuneo Andrew Officer Officer
Transaction date
Proposed sale
Price
11.50
Quantity 4,000
Value US$46,000
Cuneo Andrew See Remarks Officer
Transaction date
Planned sale
Price
10.50
Quantity 4,000 -7.9%
Value US$42,000
Cuneo Andrew Officer Officer
Transaction date
Proposed sale
Price
10.50
Quantity 4,000
Value US$42,000
3.0
Ni Xiangyang (Sean) Officer Officer
Transaction date
Proposed sale
Price
9.37
Quantity 14,937
Value US$139,940
3.0
Ni Xiangyang (Sean) President, Greater China Officer
Transaction date
Sale
Price
9.37
Quantity 14,937 -18.8%
Value US$139,942
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
9.01
Quantity 19 +0.0%
Value US$171
3.0
Ni Xiangyang (Sean) President, Greater China Officer
Transaction date
Sale
Price
11.08
Quantity 3,148 -6.4%
Value US$34,891
3.0
Ni Xiangyang (Sean) President, Greater China Officer
Transaction date
Sale
Price
11.18
Quantity 3,093 -6.9%
Value US$34,579
3.0
Ni Xiangyang (Sean) President, Greater China Officer
Transaction date
Sale
Price
11.22
Quantity 5,250 -12.4%
Value US$58,893
3.0
Ni Xiangyang (Sean) President, Greater China Officer
Transaction date
Sale
Price
10.95
Quantity 12,800 -30.5%
Value US$140,220
3.1
Taddese Menassie See Remarks Officer
Transaction date
Sale
Price
12.07
Quantity 8,813 -100.0%
Value US$106,406
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
10.42
Quantity 239 +0.3%
Value US$2,488
2.9
GOETTLER MICHAEL Chief Executive Officer Executive Director
Transaction date
Purchase
Price
9.87
Quantity 50,352 +58.2%
Value US$496,773
2.9
CORNWELL W DON Non-Executive Director
Transaction date
Purchase
Price
9.90
Quantity 2,700 +14.0%
Value US$26,721
1.2
COURY ROBERT J Executive Chairman Executive Director
Transaction date
Sale
Price
10.07
Quantity 250,000 -100.0%
Value US$2,518,275
1.2
COURY ROBERT J Executive Chairman Executive Director
Transaction date
Sale
Price
10.28
Quantity 250,000 -50.0%
Value US$2,569,050
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
10.08
Quantity 1,150 +1.2%
Value US$11,591
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
12.84
Quantity 176 +0.2%
Value US$2,261
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
13.81
Quantity 162 +0.2%
Value US$2,243
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
15.39
Quantity 145 +0.2%
Value US$2,228
2.9
CORNWELL W DON Non-Executive Director
Transaction date
Purchase
Price
15.45
Quantity 500 +11.1%
Value US$7,725
2.9
CORNWELL W DON Non-Executive Director
Transaction date
Purchase
Price
15.79
Quantity 1,500 +50.0%
Value US$23,690
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
13.94
Quantity 349 +0.4%
Value US$4,865
2.9
CORNWELL W DON Non-Executive Director
Transaction date
Purchase
Price
13.84
Quantity 3,000 +inf%
Value US$41,515
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
14.97
Quantity 713 +0.8%
Value US$10,671
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
16.99
Quantity 837 +0.9%
Value US$14,223
3.4
KILTS JAMES M Non-Executive Director
Transaction date
Purchase
Price
17.66
Quantity 27,736 +74.6%
Value US$489,693
3.0
KORMAN HARRY Non-Executive Director
Transaction date
Purchase
Price
17.15
Quantity 613 +0.7%
Value US$10,511
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-26 2026-06-25 PlS Planned sale
2.9
Campbell Paul

See Remarks

Officer
84,922 -17.3%
172.53
US$2,851,349 		84,922 -17.3% 172.53 US$2,851,349
2026-06-25 2026-06-25 PrS Proposed sale
2.9
Paul Campbell

Officer

Officer
18,531
423.05
US$607,162 		18,531 423.05 US$607,162
2026-03-24 2026-03-23 S Sale
2.9
Campbell Paul

See Remarks

Officer
49,078 -14.7%
227.69
US$139,225 		49,078 -14.7% 227.69 US$139,225
2026-03-23 2026-03-23 PrS Proposed sale
2.9
Paul Campbell

Officer

Officer
21,350
13.28
US$283,508 		21,350 13.28 US$283,508
2026-03-10 2025-11-03 B Purchase
3.0
SIMMONS DAVID S
Non-Executive Director
213 +22.0%
10.43
US$2,221 		213 +22.0% 10.43 US$2,221
2025-09-12 2025-09-11 PlS Planned sale
Le Goff Corinne

Chief Commercial Officer

Officer
7,032 -16.6%
10.25
US$72,045 		7,032 -16.6% 10.25 US$72,045
2025-09-11 2025-09-11 PrS Proposed sale
Le Goff Corinne

Officer

Officer
7,032
10.25
US$72,045 		7,032 10.25 US$72,045
2026-03-10 2025-08-27 B Purchase
3.0
SIMMONS DAVID S
Non-Executive Director
286 +41.8%
10.42
US$2,981 		286 +41.8% 10.42 US$2,981
2025-08-13 2025-08-12 B Purchase
4.1
Smith Scott Andrew

Chief Executive Officer

Executive Director
22,000 +7.5%
9.99
US$219,740 		22,000 +7.5% 9.99 US$219,740
2025-05-14 2025-05-12 B Purchase
4.1
Smith Scott Andrew

Chief Executive Officer

Executive Director
60,000 +25.8%
8.94
US$536,262 		60,000 +25.8% 8.94 US$536,262
2024-11-12 2024-11-11 PrS Proposed sale
2.9
Campbell Paul

Officer

Officer
26,925
12.88
US$346,686 		26,925 12.88 US$346,686
2024-11-12 2024-11-11 S Sale
2.9
Campbell Paul

See Remarks

Officer
26,925 -17.5%
12.88
US$346,686 		26,925 -17.5% 12.88 US$346,686
2024-09-13 2024-09-12 S Sale
1.9
Malik Rajiv
Non-Executive Director
139,681 -21.6%
11.66
US$1,628,164 		139,681 -21.6% 11.66 US$1,628,164
2024-09-13 2024-09-12 S Sale
1.9
Malik Rajiv
Non-Executive Director
60,319 -100.0%
11.71
US$706,553 		60,319 -100.0% 11.71 US$706,553
2024-08-30 2024-08-30 S Sale
1.9
Malik Rajiv
Non-Executive Director
50,000 -45.3%
12.00
US$600,000 		50,000 -45.3% 12.00 US$600,000
2024-08-30 2024-08-28 S Sale
1.9
Malik Rajiv
Non-Executive Director
50,000 -31.2%
11.90
US$595,075 		50,000 -31.2% 11.90 US$595,075
2024-08-23 2024-08-23 S Sale
1.9
Malik Rajiv
Non-Executive Director
100,000 -38.4%
11.75
US$1,175,100 		100,000 -38.4% 11.75 US$1,175,100
2024-08-23 2024-08-22 S Sale
1.9
Malik Rajiv
Non-Executive Director
100,000 -27.8%
11.73
US$1,172,630 		100,000 -27.8% 11.73 US$1,172,630
2024-08-23 2024-08-21 S Sale
1.9
Malik Rajiv
Non-Executive Director
100,000 -21.7%
11.75
US$1,175,260 		100,000 -21.7% 11.75 US$1,175,260
2024-08-20 2024-08-20 PrS Proposed sale
1.9
Malik Rajiv

Director

Non-Executive Director
600,000
11.80
US$7,080,000 		600,000 11.80 US$7,080,000
2024-06-17 2024-06-14 S Sale
1.9
Malik Rajiv
Non-Executive Director
264,300 -29.0%
10.18
US$2,690,283 		264,300 -29.0% 10.18 US$2,690,283
2024-06-17 2024-06-13 S Sale
1.9
Malik Rajiv
Non-Executive Director
85,660 -8.6%
10.52
US$900,741 		85,660 -8.6% 10.52 US$900,741
2024-06-13 2024-06-13 PrS Proposed sale
1.9
Malik Rajiv

Affiliate
350,000
10.44
US$3,654,000 		350,000 10.44 US$3,654,000
2024-05-28 2024-05-28 PrS Proposed sale
0.9
Roman Brian

Officer

Officer
89,419
10.38
US$928,427 		89,419 10.38 US$928,427
2024-05-28 2024-05-28 S Sale
0.9
Roman Brian

Chief Legal Officer

Officer
89,419 -56.9%
10.38
US$928,429 		89,419 -56.9% 10.38 US$928,429
2024-03-15 2024-03-13 S Sale
2.9
Mauro Anthony

See Remarks

Officer
250,000 -50.7%
12.09
US$3,023,700 		250,000 -50.7% 12.09 US$3,023,700
2024-03-11 2024-03-11 PrS Proposed sale
2.9
Mauro Anthony

Officer

Officer
250,000
12.30
US$3,075,000 		250,000 12.30 US$3,075,000
2024-03-05 2024-03-05 PrS Proposed sale
2.9
Campbell Paul

Officer

Officer
24,353
12.33
US$300,272 		24,353 12.33 US$300,272
2024-03-05 2024-03-05 PrS Proposed sale
Lyons Dillon JoEllen

Director

Non-Executive Director
20,000
12.36
US$247,200 		20,000 12.36 US$247,200
2024-03-05 2024-03-05 S Sale
2.9
Campbell Paul

See Remarks

Officer
24,353 -13.7%
12.33
US$300,272 		24,353 -13.7% 12.33 US$300,272
2024-03-05 2024-03-05 PlS Planned sale
Lyons Dillon JoEllen
Non-Executive Director
20,000 -25.4%
12.36
US$247,200 		20,000 -25.4% 12.36 US$247,200
2024-03-05 2024-03-04 S Sale
3.0
Ni Xiangyang (Sean)

President, Greater China

Officer
3,777 -4.0%
12.36
US$46,677 		3,777 -4.0% 12.36 US$46,677
2024-03-05 2024-03-04 S Sale
3.0
Ni Xiangyang (Sean)

President, Greater China

Officer
17,755 -15.8%
12.54
US$222,637 		17,755 -15.8% 12.54 US$222,637
2024-03-04 2024-03-04 PrS Proposed sale
3.0
Ni Xiangyang (Sean)

Officer

Officer
22,000
12.54
US$275,880 		22,000 12.54 US$275,880
2024-02-23 2024-02-23 PrS Proposed sale
Cuneo Andrew

Officer

Officer
4,000
13.50
US$54,000 		4,000 13.50 US$54,000
2024-02-23 2024-02-23 PlS Planned sale
Cuneo Andrew

See Remarks

Officer
4,000 -10.3%
13.50
US$54,000 		4,000 -10.3% 13.50 US$54,000
2024-02-16 2024-02-15 PlS Planned sale
Cuneo Andrew

See Remarks

Officer
4,000 -9.3%
12.50
US$50,000 		4,000 -9.3% 12.50 US$50,000
2024-02-15 2024-02-15 PrS Proposed sale
Cuneo Andrew

Officer

Officer
4,000
12.50
US$50,000 		4,000 12.50 US$50,000
2024-01-05 2024-01-04 PlS Planned sale
Cuneo Andrew

See Remarks

Officer
4,000 -8.5%
11.50
US$46,000 		4,000 -8.5% 11.50 US$46,000
2024-01-04 2024-01-04 PrS Proposed sale
Cuneo Andrew

Officer

Officer
4,000
11.50
US$46,000 		4,000 11.50 US$46,000
2023-12-15 2023-12-14 PlS Planned sale
Cuneo Andrew

See Remarks

Officer
4,000 -7.9%
10.50
US$42,000 		4,000 -7.9% 10.50 US$42,000
2023-12-14 2023-12-14 PrS Proposed sale
Cuneo Andrew

Officer

Officer
4,000
10.50
US$42,000 		4,000 10.50 US$42,000
2023-11-24 2023-11-24 PrS Proposed sale
3.0
Ni Xiangyang (Sean)

Officer

Officer
14,937
9.37
US$139,940 		14,937 9.37 US$139,940
2023-11-24 2023-11-24 S Sale
3.0
Ni Xiangyang (Sean)

President, Greater China

Officer
14,937 -18.8%
9.37
US$139,942 		14,937 -18.8% 9.37 US$139,942
2024-10-25 2023-10-26 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
19 +0.0%
9.01
US$171 		19 +0.0% 9.01 US$171
2023-03-06 2023-03-06 S Sale
3.0
Ni Xiangyang (Sean)

President, Greater China

Officer
3,148 -6.4%
11.08
US$34,891 		3,148 -6.4% 11.08 US$34,891
2023-03-06 2023-03-03 S Sale
3.0
Ni Xiangyang (Sean)

President, Greater China

Officer
3,093 -6.9%
11.18
US$34,579 		3,093 -6.9% 11.18 US$34,579
2023-03-01 2023-02-28 S Sale
3.0
Ni Xiangyang (Sean)

President, Greater China

Officer
5,250 -12.4%
11.22
US$58,893 		5,250 -12.4% 11.22 US$58,893
2022-11-25 2022-11-25 S Sale
3.0
Ni Xiangyang (Sean)

President, Greater China

Officer
12,800 -30.5%
10.95
US$140,220 		12,800 -30.5% 10.95 US$140,220
2022-08-19 2022-08-17 S Sale
1.7
van der Meer Mohr Pauline
Non-Executive Director
9,440 -31.5%
10.58
US$99,912 		9,440 -31.5% 10.58 US$99,912
2022-05-27 2022-05-27 S Sale
3.1
Taddese Menassie

See Remarks

Officer
8,813 -100.0%
12.07
US$106,406 		8,813 -100.0% 12.07 US$106,406
2024-10-25 2022-03-16 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
239 +0.3%
10.42
US$2,488 		239 +0.3% 10.42 US$2,488
2022-03-15 2022-03-15 B Purchase
2.9
GOETTLER MICHAEL

Chief Executive Officer

Executive Director
50,352 +58.2%
9.87
US$496,773 		50,352 +58.2% 9.87 US$496,773
2022-03-15 2022-03-15 B Purchase
2.9
CORNWELL W DON
Non-Executive Director
2,700 +14.0%
9.90
US$26,721 		2,700 +14.0% 9.90 US$26,721
2022-03-11 2022-03-11 S Sale
1.2
COURY ROBERT J

Executive Chairman

Executive Director
250,000 -100.0%
10.07
US$2,518,275 		250,000 -100.0% 10.07 US$2,518,275
2022-03-11 2022-03-09 S Sale
1.2
COURY ROBERT J

Executive Chairman

Executive Director
250,000 -50.0%
10.28
US$2,569,050 		250,000 -50.0% 10.28 US$2,569,050
2024-10-25 2022-03-04 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
1,150 +1.2%
10.08
US$11,591 		1,150 +1.2% 10.08 US$11,591
2024-10-25 2021-12-16 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
176 +0.2%
12.84
US$2,261 		176 +0.2% 12.84 US$2,261
2024-10-25 2021-09-16 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
162 +0.2%
13.81
US$2,243 		162 +0.2% 13.81 US$2,243
2024-10-25 2021-06-16 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
145 +0.2%
15.39
US$2,228 		145 +0.2% 15.39 US$2,228
2021-05-21 2021-05-21 B Purchase
2.9
CORNWELL W DON
Non-Executive Director
500 +11.1%
15.45
US$7,725 		500 +11.1% 15.45 US$7,725
2021-05-21 2021-05-19 B Purchase
2.9
CORNWELL W DON
Non-Executive Director
1,500 +50.0%
15.79
US$23,690 		1,500 +50.0% 15.79 US$23,690
2024-10-25 2021-03-09 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
349 +0.4%
13.94
US$4,865 		349 +0.4% 13.94 US$4,865
2021-03-04 2021-03-03 B Purchase
2.9
CORNWELL W DON
Non-Executive Director
3,000 +inf%
13.84
US$41,515 		3,000 +inf% 13.84 US$41,515
2024-10-25 2021-02-25 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
713 +0.8%
14.97
US$10,671 		713 +0.8% 14.97 US$10,671
2024-10-25 2021-01-15 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
837 +0.9%
16.99
US$14,223 		837 +0.9% 16.99 US$14,223
2020-12-18 2020-12-16 B Purchase
3.4
KILTS JAMES M
Non-Executive Director
27,736 +74.6%
17.66
US$489,693 		27,736 +74.6% 17.66 US$489,693
2024-10-25 2020-12-11 B Purchase
3.0
KORMAN HARRY
Non-Executive Director
613 +0.7%
17.15
US$10,511 		613 +0.7% 17.15 US$10,511
Explore more

More insider trading research around Viatris Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America
Insider trades in S&P 500